An analysis of more than 93,000 births ties the gap to a hospital policy: in hospital circumcision requires the shot, an institutional nudge that leaves girls exposed to a rare but dangerous bleed.
By 2025, 20 of every 1,000 female newborns at three University of Pennsylvania-affiliated hospitals left the birth admission without a vitamin K shot, about double the rate for boys, according to a study published June 15 in JAMA Network Open by Children's Hospital of Philadelphia researchers. The gap, drawn from medical records for more than 93,000 infants born between 2018 and 2025, has a structural cause: those hospitals will not perform in-hospital circumcision unless parents accept vitamin K.
The vitamin K shot is a one-time injection given to newborns within hours of birth. It prevents vitamin K deficiency bleeding, a rare but potentially fatal condition in which a baby's blood cannot clot properly in the first weeks of life. The shot has been the universal U.S. standard since 1961 and is routinely administered unless parents explicitly decline.
That structural coupling is what makes the new finding a sex story rather than a general vaccine-refusal story. The hospitals' circumcision policy effectively forces a yes for boys: a parent who wants the procedure performed before discharge has no path to it without accepting vitamin K. There is no analogous procedure for girls, so the institutional nudge points one direction. Two-thirds of vitamin K refusals in the dataset were for female newborns.
The research team, based at CHOP, traces the asymmetric pattern to that mechanism rather than to any clinical reason to treat boys and girls differently. The vitamin K shot is recommended for all newborns regardless of sex; the gap is a byproduct of which refusals the hospital's own policy prevents.
The constructive response the authors offer is sex-specific. Rather than a new mandate, they recommend targeted counseling and outreach for the families of girls, the population the hospital's structural nudge does not reach. That prescription, which preserves parental choice while closing the gap, is a real, agency-expanding intervention.
The larger trend is harder to fix with outreach. Overall vitamin K refusal rose during the study window, and 83% of vitamin K refusers also declined the hepatitis B birth-dose vaccine. That co-occurrence points to a shared driver: misinformation about routine newborn care. The sex gap is the news, but the underlying refusal pattern, the researchers warn, is climbing, and a rare but preventable bleeding disorder is what happens when it does.
The findings come from a single Philadelphia health system, so national generalizability is not established from this source alone. Adjusted odds ratios, confidence intervals, and demographic breakdowns should be checked against the primary JAMA Network Open article before any policy claim is loaded with weight. What is clear from the source is the mechanism: a 65-year-old universal standard, coupled to a procedure that only boys can receive, produces a sex gap that no individual parent or pediatrician intended. The authors' own prescription, sex-specific counseling outreach for families of girls, is the watch item.